FCX
47
-9
JPM
60
-2
HD
57
3
VMC
57
3
EQT
19
-5
SNA
53
-3
COF
60
-4
WEC
45
9
UNP
50
4
DNB
36
2
OKE
62
-2
NVDA
60
-5
URBN
70
4
AEP
56
-2
SCHW
49
3
ROK
43
-4
OMC
53
3
AMAT
60
-4
SLG
71
-4
ILMN
36
10
FCX
47
-9
JPM
60
-2
HD
57
3
VMC
57
3
EQT
19
-5
SNA
53
-3
COF
60
-4
WEC
45
9
UNP
50
4
DNB
36
2
OKE
62
-2
NVDA
60
-5
URBN
70
4
AEP
56
-2
SCHW
49
3
ROK
43
-4
OMC
53
3
AMAT
60
-4
SLG
71
-4
ILMN
36
10
Financhill
Back

American Express Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
66

AXP
American Express

Last Price:
231.54
Seasonality Move:
0.3%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.45
Seasonality Move:
3.65%
Buy
66
American Express (AXP) is a Buy

Is American Express a Buy, Sell or Hold?

  • The current American Express [AXP] share price is $230.38. The Score for AXP is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • AXP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AXP Stock Price Chart

What is American Express's stock price today?

  • The American Express share price today is $230.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXP is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

AXP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.99 Sell
Relative Strength Index (14 RSI): 47.07 Sell
Chaikin Money Flow: 2985575 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (228.13 - 240.25) Sell
Bollinger Bands (100): (214.71 - 236.01) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

AXP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 226.72 Buy
20-day SMA: 232.25 Sell
50-day SMA: 233.08 Sell
200-day SMA: 195.19 Buy
8-day EMA: 229.08 Buy
20-day EMA: 231.26 Sell
50-day EMA: 230.59 Sell
200-day EMA: 205.23 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

American Express Earnings Growth & AXP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, an increase next quarter of $0.40 per share, an increase this year of $1.71 per share, and an increase next year of $1.94 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

American Express Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):